Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

19.90

-0.09 (-0.43%)

Aug 14, 2025, 2:33 PM - Market open

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,179	1,099	570	-	-	-
Market Cap Growth	7.65%	92.74%	-	-	-	-
Enterprise Value	693	808	307	-	-	-
Last Close Price	19.98	22.50	13.84	-	-	-
PB Ratio	2.13	3.55	2.32	-	-	-
P/TBV Ratio	2.42	3.55	2.32	-	-	-
Debt / Equity Ratio	-	-	0.00	0.01	0.00	0.00
Quick Ratio	32.25	19.70	9.78	7.78	19.13	88.20
Current Ratio	32.58	19.99	10.28	8.00	19.24	88.35
Return on Equity (ROE)	-25.26%	-32.04%	-44.90%	-41.90%	-20.94%	-
Return on Assets (ROA)	-17.19%	-21.87%	-28.94%	-24.66%	-12.67%	-
Return on Capital (ROIC)	-18.00%	-23.50%	-32.14%	-26.86%	-13.08%	-
Earnings Yield	-8.47%	-8.10%	-12.55%	-	-	-
FCF Yield	-	-6.66%	-10.77%	-	-	-
Buyback Yield / Dilution	-16.08%	-32.43%	-1037.74%	60.02%	-56.70%	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q